找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Biomarkers in Liver Disease; Victor R. Preedy Living reference work 20200th edition

[復(fù)制鏈接]
查看: 55159|回復(fù): 67
樓主
發(fā)表于 2025-3-21 17:31:31 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
期刊全稱Biomarkers in Liver Disease
影響因子2023Victor R. Preedy
視頻videohttp://file.papertrans.cn/188/187817/187817.mp4
發(fā)行地址Bridges intellectual divides and useful for student nurses and advanced practitioners.Written by experts.Each chapter has an abstract, key facts, definition of words and terms, potential applications
學(xué)科分類Biomarkers in Disease: Methods, Discoveries and Applications
圖書封面Titlebook: Biomarkers in Liver Disease;  Victor R. Preedy Living reference work 20200th edition
影響因子In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc.In many instances these developments have gone hand in hand with the discovery of biomarkers elucidated via traditional or conventional methods, such as histopathology or clinical biochemistry.Together with microprocessor-based data analysis, advanced statistics and bioinformatics these markers have been used to identify individuals with active disease or pathology as well as those who are refractory or have distinguishing pathologies.New analytical methods that have been used to identify markers of disease and is suggested that there may be as manyas 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of mar
Pindex Living reference work 20200th edition
The information of publication is updating

書目名稱Biomarkers in Liver Disease影響因子(影響力)




書目名稱Biomarkers in Liver Disease影響因子(影響力)學(xué)科排名




書目名稱Biomarkers in Liver Disease網(wǎng)絡(luò)公開度




書目名稱Biomarkers in Liver Disease網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Biomarkers in Liver Disease被引頻次




書目名稱Biomarkers in Liver Disease被引頻次學(xué)科排名




書目名稱Biomarkers in Liver Disease年度引用




書目名稱Biomarkers in Liver Disease年度引用學(xué)科排名




書目名稱Biomarkers in Liver Disease讀者反饋




書目名稱Biomarkers in Liver Disease讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:38:05 | 只看該作者
Konservative Frakturenbehandlunge liver biomarkers. Blood EVs from patients appeared to play a detrimental role contributing disease progression. Blocking blood EV elevation by pharmacological approaches afforded protection against liver damage. Circulating EVs are emerging as a rich source of new biomarkers for liver diseases.
板凳
發(fā)表于 2025-3-22 01:15:41 | 只看該作者
地板
發(fā)表于 2025-3-22 07:57:35 | 只看該作者
Hans-Bernd Sch?fer,Hans-Jürgen Lwowskiis between 1 and 8 months. Due to the fact that liver cells are permanently replaced, there is always some ALAT detectable in the bloodstream. An elevation of ALAT of 15 times above ULN has a 100?% sensitivity for a liver disease.
5#
發(fā)表于 2025-3-22 11:27:09 | 只看該作者
6#
發(fā)表于 2025-3-22 16:12:50 | 只看該作者
7#
發(fā)表于 2025-3-22 17:19:03 | 只看該作者
https://doi.org/10.1007/978-3-322-95497-8gnosis and surveillance of HCC. In this book chapter, the focus is put on the role of serum AFP in the composition of tumor staging systems and monitoring of treatment response for clinical uses in HCC.
8#
發(fā)表于 2025-3-22 21:38:40 | 只看該作者
9#
發(fā)表于 2025-3-23 03:17:52 | 只看該作者
10#
發(fā)表于 2025-3-23 06:12:48 | 只看該作者
https://doi.org/10.1007/978-3-662-02086-9 those who would benefit the most from diagnostic, therapeutic guidance, and prognostic perspectives..In this regard, the aim of this chapter will be to examine histological biomarkers of NAFLD in order to give readers a guide about diagnosis and follow-up of this kind of disease.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 02:34
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
沽源县| 堆龙德庆县| 湟源县| 卢湾区| 绥江县| 曲阜市| 锡林郭勒盟| 太和县| 同仁县| 宁海县| 黄骅市| 昌邑市| 琼中| 会昌县| 武宁县| 黄冈市| 湘潭市| 承德市| 桦甸市| 广州市| 吉林省| 红河县| 朔州市| 博爱县| 札达县| 通辽市| 庄河市| 上高县| 江源县| 宁津县| 云安县| 吴堡县| 平山县| 太仓市| 明光市| 凤阳县| 霞浦县| 莱西市| 浠水县| 奈曼旗| 白玉县|